Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Mar 24, 2009


David Matthews has been named chief financial officer at Med BioGene, the Vancouver, BC-based firm said last week.

Matthews served previously as a director for BMO Capital, a subsidiary of the Bank of Montreal. Prior to that, he was the managing director of Aspreva Pharmaceuticals, the European subsidiary of Aspreva Pharmaceuticals, now Galenica Group. Matthews also was CFO of StressGen Biotechnologies and Allelix Biopharmaceuticals.

Richard Sauer has been promoted to chief financial officer at Network Engineering Technologies. He previously was controller and senior director of materials management at Roche NimbleGen.

Following the retirement of Steven Gutman as director of the US Food and Drug Administration's Office of In Vitro Diagnostics, Don St. Pierre is serving as the acting director of the division until a permanent director is hired.

OIVD has been interviewing candidates and a permanent director is expected to be hired by this spring, according to Alberto Gutierrez, deputy office director of new product evaluation at OIVD, who spoke at meeting of the HHS Secretary's Advisory Committee on Genetics, Health, and Society last week in Washington, DC.

The International Society for Computational Biology has named Webb Miller, of Pennsylvania State University, the winner of the Senior Scientist Award for 2009; and Trey Ideker, of the University of California, San Diego, the winner of the 2009 Overton Prize.

The senior scientist award recognizes members of the computational biology community who have made major contributions to research, education, and service, and the Overton Prize recognizes outstanding accomplishment by an early-career or mid-career scientist involved in computational biology.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.